Renovaro Biosciences Inc. (NASDAQ: RENB)
$1.41
+0.0100 ( +0.71% ) 143.7K
Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.
Market Data
Open
$1.41
Previous close
$1.40
Volume
143.7K
Market cap
$218.58M
Day range
$1.39 - $1.45
52 week range
$0.66 - $5.25
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Feb 22, 2024 |
| 4 | Insider transactions | 1 | Feb 20, 2024 |
| 8-k | 8K-related | 14 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 16, 2024 |
| 3/a | Insider transactions | 1 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 16, 2024 |
| 4 | Insider transactions | 1 | Feb 15, 2024 |
| 8-k | 8K-related | 21 | Feb 14, 2024 |
| 10-q | Quarterly Reports | 94 | Feb 14, 2024 |